A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cbc.ca)